Nebraska Supreme Court Upholds Medical Cannabis Voter Initiatives

Constitutional Challenge Rejected on Procedural Grounds

The Nebraska Supreme Court dismissed the challenge without reaching the merits of the single-subject claim. Plaintiffs argued that the two ballot measures—one establishing a medical cannabis regulatory framework and one legalizing possession—violated the state constitution's single-subject rule by bundling multiple policy questions. But the court's opinion turned on standing and timeliness rather than substantive constitutional analysis.

On a strict reading of Nebraska's election-contest statute, the court found challengers failed to meet the statutory prerequisites for pre-certification review. The November 2024 measures passed with 70.1% (Initiative 437, the regulatory framework) and 66.8% (Initiative 438, the legalization provision) voter approval.

Two-Initiative Structure Survived Legal Scrutiny

Initiative 437 created the Nebraska Medical Cannabis Commission and directed it to promulgate rules for cultivation, testing, dispensing, and physician certification. Initiative 438 separately amended Nebraska Revised Statutes §28-401 to exempt qualified patients and caregivers from criminal penalties for possession of up to 5 ounces of usable cannabis and 10 grams of concentrate.

The bifurcated structure was intentional. Campaign organizers separated the regulatory apparatus from the legalization provision to insulate each from single-subject challenges that had invalidated prior Nebraska cannabis initiatives in 2020 and 2022. That strategy worked. The court declined to consolidate the measures for constitutional analysis.

Program Implementation Timeline Remains Uncertain

The ruling doesn't mandate an implementation date, leaving the Medical Cannabis Commission's rulemaking schedule open-ended. State statute requires the commission to adopt final rules within 18 months of the measures' effective date, which was January 1, 2025. That deadline—July 1, 2026—has already passed without published regulations.

Resource constraints and pending litigation caused the delay, the commission says. With the legal challenge now resolved, the commission faces pressure to publish a Notice of Proposed Rulemaking (NPRM) for cultivation licenses, testing protocols, and dispensary siting requirements. No NPRM has been filed as of this publication date.

Tax Structure and Revenue Projections Under Review

Initiative 437 imposes a 10% excise tax on gross receipts from medical cannabis sales, in addition to the state's 5.5% general sales tax. The combined 15.5% effective rate applies at the point of retail sale. Revenue from the excise tax is earmarked for the Medical Cannabis Regulatory Fund, which finances commission operations, with surplus directed to the state's General Fund after FY2028.

The Nebraska Department of Revenue projected $12–18 million in annual excise-tax collections once the program reaches steady state, assuming 25,000–35,000 registered patients and an average per-patient annual spend of $2,400. Those estimates predate the two-year implementation delay and haven't been updated to reflect current patient-demand modeling.

Federal Tax Implications Remain Unresolved

Nebraska-licensed cannabis businesses will face IRC §280E disallowance of ordinary business deductions because cannabis remains a Schedule I controlled substance under federal law. Section 280E prohibits deductions for expenses related to trafficking in Schedule I or II substances, forcing dispensaries and cultivators to calculate federal taxable income on gross receipts minus cost of goods sold (COGS) only.

A Nebraska dispensary operating at 40% gross margin and 25% net margin pre-280E would face an effective federal tax rate of roughly 70–80% of net income, assuming no state-level conformity relief. Nebraska doesn't conform to federal taxable income for corporate income tax purposes, instead using a separate state-specific calculation under Neb. Rev. Stat. §77-2734.01, which may allow certain deductions disallowed federally. Operators should model both scenarios.

Next Procedural Milestones

The Medical Cannabis Commission must now publish its cultivation-license application framework and dispensary-siting rules. State statute caps the number of cultivation licenses at 100 statewide and limits dispensaries to 10 per county, with population-based adjustments for counties exceeding 100,000 residents. Lancaster County (Lincoln) and Douglas County (Omaha) are expected to receive the maximum allocation.

For comprehensive analysis of Nebraska's regulatory structure and compliance requirements, see the CannIntel topic hub on Nebraska Medical Cannabis Program. License applications aren't expected to open before Q2 2027.